Meloxicam Therapy
Friedreich's ataxia is a hereditary disease characterized by a violation of the transmembrane transport of iron and the death of the most energy-dependent cells of the body: neurons, cardiomyocytes, pancreatic cells, cells of the retina and the musculoskeletal system. In this article, we will talk about the symptoms of this disease, about the diagnosis and possible treatment of the disease. Among hereditary ataxias, this type is most common: 2-7 people per 100,000 of the population are diagnosed with this pathology. The manifestations of the disease can be found in a wide variety ofspecialists: neuropathologists, cardiologists, orthopedists, oculists, endocrinologists. Molecular DNA testing plays a major role in the diagnosis of Friedreich's disease. The treatment of this pathology has not yet come to an end, the solution lies within the limits of Meloxicam genetics. There is an interesting feature: representatives of the Negroid race are not subject to Friedreich's ataxia.